Yifan Wu

1.2k citations
45 papers · 932 indexed · 1 hit paper · h-index 16
Topics
Pharmacogenetics and Drug Metabolism (5 papers)Influenza Virus Research Studies (4 papers)Drug Transport and Resistance Mechanisms (4 papers)
Journals
SHILAP Revista de lepidopterologíaChemical CommunicationsEnergy Conversion and Management

In The Last Decade

Yifan Wu

40 papers receiving 917 citations

Hit Papers

Exosomes from M1-Polarized Macrophages Enhance Paclitaxel...20192026202120232019100200300

Peers

Yifan Wu
Comparison fields: 5 of 105
  • Molecular Biology 537
  • Cancer Research 246
  • Immunology 181
  • Biomedical Engineering 147
  • Epidemiology 99
Replace Jialing Zhang with:
Jialing Zhang China
Yu Jin Lee South Korea
Jia‐Yu Zhong China
Li Wu China
Yanyu Chen China
Lili Huang China
Jing Jiang China
Di Zhang China
Dan Zhao China
Mao Luo China
Yifan Wu relative to Jialing Zhang China Jialing Zhang's profile →
Citations per field
00.5×1.5×2.1×
Jialing Zhang · 1×
Citations per year

Countries citing papers authored by Yifan Wu

Since Specialization
Citations

This map shows the geographic impact of Yifan Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yifan Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yifan Wu more than expected).

Fields of papers citing papers by Yifan Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yifan Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yifan Wu. The network helps show where Yifan Wu may publish in the future.

Co-authorship network of co-authors of Yifan Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Yifan Wu. A scholar is included among the top collaborators of Yifan Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yifan Wu. Yifan Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 9
2 0
3 1
4 4
5 1
6 1
7 2
8 4
9 29
10 3
11 31
12 12
13 23
14 63
15 10
16 44
17 16
18 3
19 4
20 27

About Yifan Wu

Yifan Wu is a scholar working on Pharmacology, Aging and Nephrology, having authored 45 papers that have together received 932 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (5 papers), Influenza Virus Research Studies (4 papers) and Drug Transport and Resistance Mechanisms (4 papers). The work is most often cited by research in Cancer Research (246 citations), Immunology (181 citations) and Nephrology (58 citations). Yifan Wu has collaborated with scholars based in China, Hong Kong and United Kingdom. Frequent co-authors include Weidong Chen, Huihui Wang, Lei Wang, Liang Yao, Zhen Qiu, Hong Chen, Can Peng, Qianqian Huang, Yan Huang and Jiuyao Zhou. Their work appears in journals such as SHILAP Revista de lepidopterología, Chemical Communications and Energy Conversion and Management.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026